Prevention of Esophageal Cancer with Berries
用浆果预防食道癌
基本信息
- 批准号:6925381
- 负责人:
- 金额:$ 46.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-08-01 至 2008-05-31
- 项目状态:已结题
- 来源:
- 关键词:apoptosisbiological signal transductioncancer preventioncarcinogenesiscell proliferationcell transformationchemopreventioncombination chemotherapycysteine endopeptidasescytochrome P450cytochrome cdisease /disorder modelenzyme activityenzyme linked immunosorbent assayesophagus neoplasmfruithigh performance liquid chromatographyisothiocyanateslaboratory ratneoplasm /cancer pharmacologyneoplastic processnitrosaminesnutrition aspect of cancerpolymerase chain reactionsquamous cell carcinomatoxicology
项目摘要
DESCRIPTION (provided by applicant): Squamous cell carcinoma (SCC) of the human esophagus is a multifactorial disease with a significant behavorial component. Primary chemoprevention has emerged as a potentially viable approach to reduce the risk of esophageal cancer in high-risk individuals. N-Nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in the F-344 rat has proven to be a useful animal model for investigations of SCC of the esophagus. For the last fifteen years, the goal of our laboratory has been to identify effective chemopreventive agents for the disease using this animal model. Our previous work (5-10 years ago) with isothiocyanates demonstrated that phenethyl isothiocyanate (PEITC) and 3- phenylpropyl isothiocyanate (PPITC) are exquisitely potent inhibitors of tumor initiation (i.e., blocking agents) in the rat esophagus. However, at that time, there were few, if any, demonstrable inhibitors of the promotion/progression stages of rat esophageal tumorigenesis (i.e., suppressing agents). Thus, the past five years have been largely devoted to the discovery of non-isothiocyanate chemopreventive agents in this model, particularly the identification of potent suppressing agents. We have found that lyophilized black raspberries (BRB) act as an effective chemopreventive agent in the model, and that BRB exhibit both blocking and suppressing activity. Our preliminary data indicate that BRB exhibit blocking activity by influencing the metabolism of NMBA, thus reducing the levels of NMBA-induced damage in esophageal DNA. At least one mechanism by which BRB exhibit suppressing activity is by reducing the growth rate of preneoplastic esophageal epithelial cells. The ultimate goals of the proposed project are to develop an improved understanding of the mechanism(s) by which BRB exhibit blocking and suppressing activity in the rat esophagus and to develop an effective "cocktail" of chemopreventive agents for later use in the primary chemoprevention of human esophageal SCC. Accordingly, we propose the following Specific Aims for our future investigations: (1) to identify the active inhibitory components of lyophilized BRB; (2) to determine the mechanistic basis of the anti-initiating effects of lyophilized BRB; (3) to investigate the mechanistic basis of the suppressing effects of lyophilized BRB; (4) to test the chemopreventive efficacies of specific compounds isolated from lyophilized BRB or specific BRB extracts; and (5) to evaluate the combined effects of BRB isolates and isothiocyanates on rat esophageal tumorigenesis.
描述(由申请人提供):人类食管的鳞状细胞癌(SCC)是一种多因素疾病,具有重要的遗殖成分。原发性预防已成为降低高危个体食管癌风险的潜在可行方法。 N-亚硝基甲基苯胺(NMBA)诱导的F-344大鼠食管肿瘤发生已被证明是研究食道SCC的有用动物模型。在过去的十五年中,我们实验室的目标是使用该动物模型鉴定有效的化学预防剂。我们先前使用异硫氰酸酯的工作(5-10年前)表明,异硫氰酸苯基(PEITC)和3-苯基丙基异硫氰酸酯(PPITC)是对大鼠食管中肿瘤起始(即阻断剂)的明显有效抑制剂。但是,当时,大鼠食管肿瘤发生的促进/进展阶段(即抑制剂)的促进/进展阶段的抑制很少(如果有的话)。因此,在过去的五年中,在该模型中发现了非异硫氰酸酯化学预防剂,特别是鉴定有效抑制剂。我们发现,冻干的黑色覆盆子(BRB)在模型中充当了一种有效的化学预防剂,并且BRB表现出阻塞和抑制活性。我们的初步数据表明,BRB通过影响NMBA的代谢而表现出阻塞活性,从而降低了NMBA诱导的食管DNA损伤水平。 BRB表现出抑制活性的至少一种机制是通过降低产质食管上皮细胞的生长速率。拟议项目的最终目标是对BRB在大鼠食道中表现出阻塞和抑制活性的机制有了改进的理解,并开发了化学预防剂的有效“鸡尾酒”,以便以后在人类食管SCC的主要化学预防中使用。因此,我们提出了以下对未来研究的特定目标:(1)确定冻干BRB的活跃抑制成分; (2)确定冻干BRB的抗发射作用的机械基础; (3)研究冻干BRB抑制作用的机理基础; (4)测试从冻干BRB或特定BRB提取物中分离出的特定化合物的化学预防效应; (5)评估BRB分离株和异硫氰酸盐对大鼠食管肿瘤发生的综合作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gary Stoner其他文献
Gary Stoner的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gary Stoner', 18)}}的其他基金
Chemoprevention of Esophageal Squamous Cell Carcinoma
食管鳞状细胞癌的化学预防
- 批准号:
6765080 - 财政年份:2002
- 资助金额:
$ 46.98万 - 项目类别:
Chemoprevention of Esophageal Squamous Cell Carcinoma
食管鳞状细胞癌的化学预防
- 批准号:
6806756 - 财政年份:2002
- 资助金额:
$ 46.98万 - 项目类别:
相似国自然基金
硫化氢抑制采后枸杞乙烯生物合成及其信号转导的机理研究
- 批准号:32360612
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
生物钟核心转录因子PRRs调控JA信号转导及植物对灰霉菌防御的分子机理
- 批准号:32370606
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于“丛枝菌根真菌-激素信号转导-转录因子-L/ODC基因”调控路径解析苦参生物碱生物合成的调控机制
- 批准号:82304678
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
组蛋白乙酰化修饰ATG13激活自噬在牵张应力介导骨缝Gli1+干细胞成骨中的机制研究
- 批准号:82370988
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
新型信号转导光电化学免疫生物传感对肝癌相关分子标志物检测新方法研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
A role of balanced sex hormone in DNA repair in human melanocytes
平衡性激素在人类黑素细胞 DNA 修复中的作用
- 批准号:
10666307 - 财政年份:2023
- 资助金额:
$ 46.98万 - 项目类别:
Using natural killer cells to prevent breast cancer metastases
使用自然杀伤细胞预防乳腺癌转移
- 批准号:
10591362 - 财政年份:2023
- 资助金额:
$ 46.98万 - 项目类别:
Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer
以前列腺癌为模型的强化降胆固醇干预和抗肿瘤免疫
- 批准号:
10802975 - 财政年份:2023
- 资助金额:
$ 46.98万 - 项目类别:
Bacteria-derived xenobiotics in colon cancer prevention: Link to GPR109A and colonic ketogenesis
细菌源性异生素在结肠癌预防中的作用:与 GPR109A 和结肠生酮的联系
- 批准号:
10737017 - 财政年份:2023
- 资助金额:
$ 46.98万 - 项目类别:
The TGF-Beta/MUC4 Signaling Axis in Circulating Tumor Cells of Metastatic Breast Cancer
转移性乳腺癌循环肿瘤细胞中的 TGF-β/MUC4 信号轴
- 批准号:
10751169 - 财政年份:2023
- 资助金额:
$ 46.98万 - 项目类别: